Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;32(8):843-851.
doi: 10.1089/jwh.2022.0522.

Considering Sex as a Variable at a Research University: Knowledge, Attitudes, and Practices

Affiliations

Considering Sex as a Variable at a Research University: Knowledge, Attitudes, and Practices

Donna L Maney et al. J Womens Health (Larchmt). 2023 Aug.

Abstract

Biomedical research has a history of excluding females as research subjects, which threatens rigor, reproducibility, and inclusivity. In 2016, to redress this bias, the U.S. National Institutes of Health (NIH) implemented a policy requiring the consideration of sex as a biological variable (SABV) in all studies involving vertebrate animals, including humans. Unless strongly justified, females and males must be included in all studies and results reported disaggregated by sex. Recent evidence indicates, however, that misunderstandings of the policy and other significant barriers impede its implementation. To shed light on those barriers at our home institution, we conducted a study funded by the Emory University Specialized Center of Research Excellence on Sex Differences (SCORE). In semistructured interviews of Emory principal investigators in the biological sciences, we noted their knowledge of what the policy entails and why it was implemented, their attitudes toward it, and the extent to which it has or has not changed their research practices. Although attitudes toward SABV were generally positive, most researchers face challenges with respect to its implementation. We suggest interventions that can be mounted at the level of home institutions, such as raising awareness of locally available core facilities, to help address these challenges. More training is needed on what the policy asks of researchers, how sex is defined, the nonhormonal ways that sex differences can manifest, and best practices for statistical analysis of sex-based data. Home institutions may also want to explore ways to lessen the stress associated with rollout of SABV policy.

Keywords: NIH policy; preclinical research; sex as a biological variable; sex-inclusive research.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

FIG. 1.
FIG. 1.
The Emory SCORE comprises three main cores, which work together toward advancing the quality of women's health research at Emory University. The current study was conducted with funds from the CEC, the mission of which is to facilitate and normalize research that includes females and males.

Similar articles

Cited by

References

    1. Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 2011;35:565–572; doi: 10.1016/j.neubiorev.2010.07.002 - DOI - PMC - PubMed
    1. U. S. Department of Health and Human Services. NIH Guide for Grants and Contracts, 1986. Available from: https://grants.nih.gov/grants/guide/historical/1986_11_28_Vol_15_No_27.pdf [Last accessed: December 9, 2022].
    1. 103rd Congress. S.1 National Institutes of Health Revitalization Act, 1993. Available from: https://orwh.od.nih.gov/sites/orwh/files/docs/NIH-Revitalization-Act-199... [Last accessed: December 9, 2022].
    1. Reihl SJ, Patil N, Morshed RA, et al. . A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act. Neuro Oncol 2022;24:1341–1349; doi: 10.1093/neuonc/noac011 - DOI - PMC - PubMed
    1. Schick MR, Spillane NS, Hostetler KL. A call to action: A systematic review examining the failure to include females and members of minoritized racial/ethnic groups in clinical trials of pharmacological treatments for Alcohol Use Disorder. Alcohol Clin Exp Res 2020;44:1933–1951; doi: 10.1111/acer.14440 - DOI - PubMed

Publication types

LinkOut - more resources